Offer lisdexamfetamine or methylphenidate as first-line pharmacological treatment for adults with ADHD NICE CKS.
Consider switching to lisdexamfetamine for adults who have had a 6-week trial of methylphenidate at an adequate dose but have not derived enough benefit in terms of reduced ADHD symptoms and associated impairment NICE CKS.
Consider switching to methylphenidate for adults who have had a 6-week trial of lisdexamfetamine at an adequate dose but have not derived enough benefit NICE CKS.
Consider dexamfetamine for adults whose ADHD symptoms are responding to lisdexamfetamine but who cannot tolerate the longer effect profile NICE CKS.
Offer atomoxetine to adults if they cannot tolerate lisdexamfetamine or methylphenidate, or if their symptoms have not responded to separate 6-week trials of these medications NICE CKS.